Renascience (TSE:4889) Total Liabilities: 円180.59 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4889 Renascience Inc TSE:4889
53 GF Score
Price 円1,522.00
GF Value 円331.42
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Renascience Total Liabilities?

Renascience TSE:4889 -2.25% 53 Total Liabilities is 円180.59 Mil as of Mar. 2026. GuruFocus rates TSE:4889 with a GF Score™ of 53/100 and a GF Value™ of 円331.42 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Renascience's Total Liabilities for the quarter that ended in Mar. 2026 was 円180.59 Mil.

Renascience's quarterly Total Liabilities declined from Mar. 2025 (円151.21 Mil) to Sep. 2025 (円114.78 Mil) but then increased from Sep. 2025 (円114.78 Mil) to Mar. 2026 (円180.59 Mil).

Renascience's annual Total Liabilities declined from Mar. 2024 (円482.11 Mil) to Mar. 2025 (円151.21 Mil) but then increased from Mar. 2025 (円151.21 Mil) to Mar. 2026 (円180.59 Mil).

Renascience Total Liabilities Historical Data

* Premium members only.

The historical data trend for Renascience's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Renascience Total Liabilities Chart

Renascience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial 237.17 409.76 482.11 151.21 180.59

Renascience Semi-Annual Data
Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 482.11 423.34 151.21 114.78 180.59
TSE:4889
53GF Score
Renascience Inc TSE:4889
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Renascience Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Renascience's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=180.585+(0+0.0010000000000048
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=180.59

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=3503.263-3322.677
=180.59

Renascience's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=180.585+(0+0.0010000000000048
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=180.59

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=3503.263-3322.677
=180.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of 円180.59 Mil mean?
Renascience (TSE:4889) has a Total Liabilities of 円180.59 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Renascience and its competitors.
Is Renascience's Total Liabilities too high?
Renascience's current Total Liabilities is 円180.59 Mil. Overall, Renascience has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Renascience's Total Liabilities compare to ABT and SYK?
Renascience's Total Liabilities of 円180.59 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Renascience and its competitors. Renascience's current Total Liabilities is 円180.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Renascience stock overvalued right now?
Based on GuruFocus' analysis, Renascience (TSE:4889) is currently considered Significantly Overvalued. The stock's GF Value™ is 円331.42, compared to a current price of 円1,522.00 — trading 359.2% above its estimated fair value. The current Total Liabilities is 円180.59 Mil. Renascience's overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Renascience (TSE:4889), the current Total Liabilities is 円180.59 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Renascience (TSE:4889) Overvalued in 2026?

Based on GuruFocus' analysis, Renascience stock appears to be overvalued. The current stock price of 円1,522.00 is trading 359.2% above its estimated GF Value™ of 円331.42. GuruFocus considers Renascience to be Significantly Overvalued.

Key valuation signals for TSE:4889:

  • Total Liabilities: 円180.59 Mil
  • GF Value™: 円331.42 vs. price of 円1,522.00 (359.2% above fair value)
  • GF Score™: 53/100 with 3 warning signs

No single metric tells the full story. See the TSE:4889 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Renascience Business Description

Address 2-1 Seiryo-cho, Aoba-ku, Miyagi, Sendai, JPN, 103-0023
Renascience Inc is engaged in the Development and commercialization of pharmaceuticals, medical devices, pieces of software as a medical device (SaMD) utilizing AI, etc.
53GF Score

Get the complete analysis for TSE:4889

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,522.00
Price
円331.42
GF Value